Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic - insights from the IRONMAN trial.

Matthew Meng Yang LeeMark C PetrieJohn G F ClelandPatrick DonnellyMark FrancisAndrew HannahAlan G JappCatherine LabinjohNinian N LangCharlotte ManistyColin J PetrieSusan E PiperSimon G WilliamsIan FordPaul R Kalranull null

Published in: European journal of heart failure (2024)

Keyphrases

iron deficiency
heart failure
phase iii
study protocol
emergency department
phase ii
clinical trial
healthcare
acute care
left ventricular
adverse drug
cardiac resynchronization therapy
acute heart failure
randomized controlled trial
atrial fibrillation
open label